Is the Market Going to Go Lower?
The last month has been extremely difficult for the stock…
Sell
39
CVGW Quote, Financials, Valuation and Earnings
Last price:
$23.84
Seasonality move
:
5.3%
Day range:
$23.01 - $24.19
52-week range:
$20.30 - $30.58
Dividend yield:
2.52%
P/E ratio:
44.11x
P/S ratio:
0.62x
P/B ratio:
2.11x
Volume:
219.8K
Avg. volume:
179.6K
1-year change:
-17.46%
Market cap:
$424.9M
Revenue:
$661.5M
EPS (TTM):
$0.54
Analysts' Opinion
-
Consensus RatingCalavo Growers has received a consensus rating of Buy. The company's average rating is a Buy based on 2 Buy ratings, 1 Hold rating, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $33.00, Calavo Growers has an estimated upside of 38.54% from its current price of $23.82.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $29.00 representing 100% downside risk from its current price of $23.82.
Fair Value
-
According to the consensus of 3 analysts, Calavo Growers has 38.54% upside to fair value with a price target of $33.00 per share.
CVGW vs. S&P 500
-
Over the past 5 trading days, Calavo Growers has overperformed the S&P 500 by 0.39% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Calavo Growers does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Calavo Growers has grown year-over-year revenues for 4 quarters straight. In the most recent quarter Calavo Growers reported revenues of $154.4M.
Earnings Growth
-
Calavo Growers has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Calavo Growers reported earnings per share of $0.25.
Enterprise value:
377.8M
EV / Invested capital:
1.86x
Price / LTM sales:
0.62x
EV / EBIT:
20.14x
EV / Revenue:
0.55x
PEG ratio (5yr expected):
-0.38x
EV / Free cash flow:
21.24x
Price / Operating cash flow:
23.94x
Enterprise value / EBITDA:
14.12x
Gross Profit (TTM):
$72.5M
Return On Assets:
2.69%
Net Income Margin (TTM):
1.4%
Return On Equity:
4.71%
Return On Invested Capital:
4.14%
Operating Margin:
3.27%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-01-31 | 2024-01-31 | 2025-01-31 | 2024-01-31 | 2025-01-31 | |
| Income Statement | ||||||
| Revenue | $628.4M | $588.9M | $688.3M | $127.6M | $154.4M | |
| Gross Profit | $54.6M | $62.7M | $72.5M | $10.8M | $15.7M | |
| Operating Income | $8.5M | $12.1M | $24.6M | -$3.1M | $5M | |
| EBITDA | $19.1M | $31.2M | $26.8M | $3.4M | $7M | |
| Diluted EPS | -$0.30 | -$0.66 | $0.54 | -$0.35 | $0.25 | |
| Period Ending | 2021-01-31 | 2022-01-31 | 2023-01-31 | 2024-01-31 | 2025-01-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $145.1M | $179.5M | $132.9M | $245.6M | $158.2M | |
| Total Assets | $446.5M | $468.6M | $396.5M | $394.7M | $298.9M | |
| Current Liabilities | $81.1M | $116.9M | $105.1M | $120.9M | $70.8M | |
| Total Liabilities | $184.7M | $245.4M | $179.7M | $192.2M | $96.1M | |
| Total Equity | $261.7M | $223.3M | $216.8M | $202.5M | $202.9M | |
| Total Debt | $44.5M | $64M | $23.1M | $51M | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-01-31 | 2024-01-31 | 2025-01-31 | 2024-01-31 | 2025-01-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $42M | -$8.5M | $19.9M | $58K | -$4.4M | |
| Cash From Investing | $5.5M | -$6.5M | $80.9M | -$1M | -$282K | |
| Cash From Financing | -$54.5M | $18.9M | -$58M | $3.8M | -$3.8M | |
| Free Cash Flow | $29.1M | -$15.1M | $17.8M | -$972K | -$4.7M | |
CVGW
Sector
Market Cap
$424.9M
$284.1M
Price % of 52-Week High
77.89%
72.04%
Dividend Yield
2.52%
0%
Shareholder Yield
--
3.11%
1-Year Price Total Return
-17.46%
-11.92%
Beta (5-Year)
0.575
0.465
Dividend yield:
2.52%
Annualized payout:
$0.50
Payout ratio:
111.46%
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$22.59
200-day SMA
Sell
Level
$25.12
Bollinger Bands (100)
Sell
Level
23.23 - 27.27
Chaikin Money Flow
Buy
Level
4.8M
20-day SMA
Buy
Level
$23.11
Relative Strength Index (RSI14)
Buy
Level
55.06
ADX Line
Buy
Level
13.13
Williams %R
Sell
Level
-17.193
50-day SMA
Buy
Level
$23.48
MACD (12, 26)
Sell
Level
-0.25
25-day Aroon Oscillator
Sell
Level
-56
On Balance Volume
Neutral
Level
2.4M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (5.6364)
Buy
CA Score
(Annual)
Level (0.8904)
Buy
Beneish M-Score
(Annual)
Level (-2.4842)
Buy
Momentum Score
Level (4)
Sell
Ohlson Score
Level (2.9115)
Buy
Piotroski F Score
(Annual)
Level (6)
Sell
Quality Ratio Score
Level (3)
Sell
Fundamental Score
Level (3)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Calavo Growers Inc is in the avocado industry and an expanding provider of value-added fresh food. The group markets and distribute avocados, prepared avocado products, and other perishable foods to retail grocery, foodservice, club stores, mass merchandisers, food distributors and wholesalers across the world. The company distributes its products both domestically and internationally and reports its operations in two different business segments: Grown and Prepared. The Grown segment consists of fresh avocados, tomatoes, and papayas. The Prepared segment comprises all other products including fresh-cut fruits and vegetables, ready-to-eat sandwiches, wraps, salads and snacks, guacamole, and salsa sold at retail and food service as well as avocado pulp sold to food service.
Stock Forecast FAQ
In the current month, CVGW has received 2 Buy ratings 1 Hold ratings, and 0 Sell ratings. The CVGW average analyst price target in the past 3 months is $33.00.
-
Where Will Calavo Growers Stock Be In 1 Year?
According to analysts, the consensus estimate is that Calavo Growers share price will rise to $33.00 per share over the next 12 months.
-
What Do Analysts Say About Calavo Growers?
Analysts are divided on their view about Calavo Growers share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Calavo Growers is a Sell and believe this share price will drop from its current level to $29.00.
-
What Is Calavo Growers's Price Target?
The price target for Calavo Growers over the next 1-year time period is forecast to be $33.00 according to 3 Wall Street analysts, 2 of them rate the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.
-
Is CVGW A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Calavo Growers is a Buy. 2 of 3 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of CVGW?
You can purchase shares of Calavo Growers via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Calavo Growers shares.
-
What Is The Calavo Growers Share Price Today?
Calavo Growers was last trading at $23.84 per share. This represents the most recent stock quote for Calavo Growers. Yesterday, Calavo Growers closed at $23.82 per share.
-
How To Buy Calavo Growers Stock Online?
In order to purchase Calavo Growers stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
2 Dividend Stocks to Buy in a Recession
While many economists and investors initially expected 2025 to be…
Is Ford Stock Undervalued Amid the EV Transition?
There is a lot going on in the electric vehicle…
Stock Ideas
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
54
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 41x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Alerts
Sell
48
SMTC alert for Mar 18
Semtech [SMTC] is down 0.49% over the past day.
Buy
67
PLPC alert for Mar 18
Preformed Line Products [PLPC] is up 3.8% over the past day.
Buy
58
NUTX alert for Mar 18
Nutex Health [NUTX] is up 4.82% over the past day.
